Arterys is now offering artificial intelligence (AI)-powered software developed by Avicenna for flagging patients with neurovascular emergencies on CT on its cloud-based imaging platform.
Avicenna's Cina Head software was developed for use as an aid for radiologists in detecting large vessel occlusions and intracranial hemorrhages on CT angiography studies and directing patient management accordingly. Arterys said it has integrated the Avicenna algorithms into its own Mica platform and will make them available to its installed base in the coming weeks.
Along with other AI products, Avicenna's Cina head software now qualifies for reimbursement of up to $1,040 through the U.S. Centers for Medicare and Medicaid Services new technology add-on payment program. In a statement, Arterys said the reimbursement policy signals the readiness of AI to transform clinical practice.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
